Literature DB >> 34483757

Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical Practice.

Sarah Haines, Ernest Butler, Stephen Stuckey, Robert Hester, Lisa B Grech.   

Abstract

BACKGROUND: The lifetime prevalence of depression in people with multiple sclerosis (MS) is approximately 50% compared with around 15% in the general population. There is a relationship between depression and quality of life in people with MS and evidence that depression may contribute to disease progression.
METHODS: This cross-sectional pilot study assessed the association between depression and regional brain atrophy, including amygdala and hippocampal volume. Forty-nine participants with MS recruited through a hospital MS clinic were administered the Center for Epidemiological Studies Depression Scale Revised (CESD-R) to investigate whether higher endorsements on the items depressive affect and interpersonal symptoms were associated with volumetric magnetic resonance imaging measurements of hippocampal and amygdala atrophy.
RESULTS: Regression analysis revealed an association between depression-related interpersonal symptoms and right amygdala volume. No association was found between depression and hippocampal volume.
CONCLUSIONS: These results provide preliminary support for a unilateral, biologically based relationship between the right amygdala and characteristic interpersonal depressive symptoms expressed by people with MS and add to the growing body of literature implicating regional brain atrophy in MS-associated depression. Given that the interpersonal subcomponent of the CESD-R measures social functioning, and the neural networks in the amygdala are known to be implicated in processing social stimuli, this research suggests that targeted diagnosis and treatments for depression in people with MS may be particularly beneficial. Further confirmatory research of this relationship is required.
© 2021 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Amygdala; Clinical practice; Depression; Interpersonal; Multiple sclerosis (MS)

Year:  2020        PMID: 34483757      PMCID: PMC8405145          DOI: 10.7224/1537-2073.2020-015

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  51 in total

1.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

2.  Depression in multiple sclerosis: a long-term longitudinal study.

Authors:  Marcus W Koch; Scott Patten; Sandy Berzins; Simon Zhornitsky; Jamie Greenfield; Winona Wall; Luanne M Metz
Journal:  Mult Scler       Date:  2014-05-22       Impact factor: 6.312

Review 3.  Cognitive and affective Theory of Mind in neurodegenerative diseases: neuropsychological, neuroanatomical and neurochemical levels.

Authors:  Michele Poletti; Ivan Enrici; Mauro Adenzato
Journal:  Neurosci Biobehav Rev       Date:  2012-07-20       Impact factor: 8.989

Review 4.  Multiple sclerosis and depression.

Authors:  Anthony Feinstein
Journal:  Mult Scler       Date:  2011-11       Impact factor: 6.312

5.  Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis.

Authors:  Gevrey Kiy; Pia Lehmann; Horst K Hahn; Paul Eling; Andreas Kastrup; Helmut Hildebrandt
Journal:  Mult Scler       Date:  2011-05-05       Impact factor: 6.312

6.  Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Authors:  Stefan M Gold; Mary-Frances O'Connor; Raja Gill; Kyle C Kern; Yonggang Shi; Roland G Henry; Daniel Pelletier; David C Mohr; Nancy L Sicotte
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

7.  Impaired social cognition in multiple sclerosis.

Authors:  Jana Pöttgen; Isabel Dziobek; Susan Reh; Christoph Heesen; Stefan M Gold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-11       Impact factor: 10.154

8.  Fatigue, depression and progression in multiple sclerosis.

Authors:  M Koch; M Uyttenboogaart; A van Harten; M Heerings; J De Keyser
Journal:  Mult Scler       Date:  2008-06-05       Impact factor: 6.312

9.  Regional hippocampal atrophy in multiple sclerosis.

Authors:  N L Sicotte; K C Kern; B S Giesser; A Arshanapalli; A Schultz; M Montag; H Wang; S Y Bookheimer
Journal:  Brain       Date:  2008-04       Impact factor: 13.501

10.  A comparison of FreeSurfer-generated data with and without manual intervention.

Authors:  Christopher S McCarthy; Avinash Ramprashad; Carlie Thompson; Jo-Anna Botti; Ioana L Coman; Wendy R Kates
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.